definiens: shall mean, solely with respect to the Her2 / neu - Mammaglobin Field, ( i ) a product for use in DC Therapy that would otherwise infringe Existing c ~ xa Patents or Joint R&D Program Patents in the Her2 / neu - Mammaglobin Field, or ( ii ) enentech 's Her2 / neu monoclonal Antibody or other Her2 / neu - based Antibody therapeutIc for use in DC Therapy ; or ( iii ) Medarex 's bi­specific Her2 / neu Antibody therapeutic for use in DC Therapy ; or ( iv ) any other product in the Cancer Field for use in DC Therapy that is comprised of at least one ( 1 ) or more Antigens derived from the Her2 / neu gene, provided that the market share in any particular country of any such Competitive DC Therapy / Her2 / neu Product for a particular indication in the Cancer Field is greater than ten percent ( 10 % ) of sales of all biological immune intervention products for the treatment of such indication in any such country in any given calendar yeaIJ ( bb ) shall mean, solely with respect to products incorporating Existing [COMPANY] Antigens and/or Existing R&D Program Antigens developed solely pursuant to the Existing R&D Programs, ( i ) a product for use in DC Therapy that would otherwise infringe Existing [COMPANY] Patents, or ( ii ) any other product for use in DC Therapy comprised of at least one ( 1 ) or more Existing [COMPANY] Antigen(s ) and/or Existing R&D Program Antigen(S)j[;vided that the market ~ share in any particular country of any such Competitive Existi C Therapy Product for I a particular indication is greater than ten percent ( 10 % ) of sales of all biological immune intervention products for the treatment of such indication in such country in any given calendar ye~ ( cc ) shall mean ( i ) a Vaccine product that incorporates only Her2 / neu Antigen(s ), which Vaccine product would otherwise infringe Existing [COMPANY] Patents, or @i ) ? enentech 's Her2 / neu monoclonal Antibody or other Her2 / neu - based Antibody therapeutic ; or ( iii ) Medarex 's bi - specific Her2 / neu ¥ ' Antibody therapeutic ; or ( iv ) any other Vaccine product in the Cancer Field comprised of at least one ( 1 ) or more Antigen(s ) derived from the Her2 / neu gene, provided that .t§ ] 10015544.15 -4- * Confidential treatment is requested for the language which has been underscored or marked . Such language has been deleted from the copy filed with the SEC